Altuviiio

Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl · Bioverativ Therapeutics Inc.
PRESCRIPTION ONLY (USA)

Altuviiio ingredients

Active ingredientStrength
Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtlsee label

What Altuviiio is used for

Altuviiio is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Altuviiio
Generic name
Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
Made by
Bioverativ Therapeutics Inc.
Forms
Kit
FDA approval
Biologic licence (BLA) BLA125771
On the US market since
2023

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Altuviiio?

Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl) is a specialist medicine made by Bioverativ Therapeutics Inc., approved by the US FDA.

What are the ingredients of Altuviiio?

Altuviiio contains Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl.

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.